Induction chemotherapy followed by cisplatin or cetuximab concomitant to radiotherapy for laryngeal/hypopharyngeal cancer: Long-term results of the TREMPLIN randomised GORTEC trial - Institut de cancérologie de l'Ouest Access content directly
Journal Articles European Journal of Cancer Year : 2020

Induction chemotherapy followed by cisplatin or cetuximab concomitant to radiotherapy for laryngeal/hypopharyngeal cancer: Long-term results of the TREMPLIN randomised GORTEC trial

Fichier principal
Vignette du fichier
S0959804920302070.pdf (417.08 Ko) Télécharger le fichier
Origin Files produced by the author(s)

Dates and versions

hal-03490774 , version 1 (22-08-2022)

Licence

Identifiers

Cite

Guillaume Janoray, Yoann Pointreau, Marc Alfonsi, Christian Sire, Lionel Geoffrois, et al.. Induction chemotherapy followed by cisplatin or cetuximab concomitant to radiotherapy for laryngeal/hypopharyngeal cancer: Long-term results of the TREMPLIN randomised GORTEC trial. European Journal of Cancer, 2020, 133, pp.86 - 93. ⟨10.1016/j.ejca.2020.04.009⟩. ⟨hal-03490774⟩
61 View
153 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More